Shanghai Pharmaceuticals Holding Stock Today
| SHPMY Stock | USD 7.80 0.05 0.65% |
PerformanceWeak
| Odds Of DistressLow
|
Shanghai Pharmaceuticals is trading at 7.80 as of the 7th of February 2025; that is 0.65% increase since the beginning of the trading day. The stock's open price was 7.75. Shanghai Pharmaceuticals has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. The performance scores are derived for the period starting the 8th of January 2025 and ending today, the 7th of February 2025. Click here to learn more.
Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the Peoples Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. The company has 739.51 M outstanding shares. More on Shanghai Pharmaceuticals Holding
Moving against Shanghai Pink Sheet
Shanghai Pink Sheet Highlights
| Vice President | Yongzhong Li |
| Business Concentration | Medical Distribution, Healthcare (View all Sectors) |
Shanghai Pharmaceuticals Holding [SHPMY] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.2 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Shanghai Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Shanghai Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Shanghai Pharmaceuticals classifies itself under Healthcare sector and is part of Medical Distribution industry. The entity has 739.51 M outstanding shares.
Shanghai Pharmaceuticals Holding has accumulated about 37.3 B in cash with 5.06 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 50.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Shanghai Pharmaceuticals Probability Of Bankruptcy
Shanghai Pharmaceuticals Risk Profiles
| Mean Deviation | 1.63 | |||
| Standard Deviation | 2.68 | |||
| Variance | 7.19 | |||
| Risk Adjusted Performance | (0.01) |
Shanghai Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Shanghai Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Shanghai Pharmaceuticals Corporate Management
| Ying Ke | Director Center | Profile | |
| Tao Zhong | Board VP | Profile | |
| Man Cho | Pres Director | Profile | |
| Jinqi Yu | G Mang | Profile | |
| Shunjiang Yu | Chief Officer | Profile | |
| Shui ACS | Joint Sec | Profile |
Additional Tools for Shanghai Pink Sheet Analysis
When running Shanghai Pharmaceuticals' price analysis, check to measure Shanghai Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Pharmaceuticals is operating at the current time. Most of Shanghai Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Shanghai Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Pharmaceuticals' price. Additionally, you may evaluate how the addition of Shanghai Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.